These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma. Xiang XJ, Liu YW, Zhang L, Qiu F, Yu F, Zhan ZY, Feng M, Yan J, Zhao JG, Xiong JP. Anticancer Drugs; 2012 Jun; 23(5):561-6. PubMed ID: 22481063 [Abstract] [Full Text] [Related]
3. Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Zaanan A, Costes L, Gauthier M, Malka D, Locher C, Mitry E, Tougeron D, Lecomte T, Gornet JM, Sobhani I, Moulin V, Afchain P, Taïeb J, Bonnetain F, Aparicio T. Ann Oncol; 2010 Sep; 21(9):1786-1793. PubMed ID: 20223786 [Abstract] [Full Text] [Related]
4. Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China. Zhang L, Wang LY, Deng YM, Wang FH, Feng F, Chen YC, An X, Chen C, Xu RH, Li YH. J BUON; 2011 Sep; 16(4):689-96. PubMed ID: 22331723 [Abstract] [Full Text] [Related]
5. Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine. Ono M, Shirao K, Takashima A, Morizane C, Okita N, Takahari D, Hirashima Y, Eguchi-Nakajima T, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Gastric Cancer; 2008 Sep; 11(4):201-5. PubMed ID: 19132481 [Abstract] [Full Text] [Related]
8. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. Polyzos A, Kouraklis G, Giannopoulos A, Bramis J, Delladetsima JK, Sfikakis PP. J Chemother; 2003 Oct; 15(5):503-6. PubMed ID: 14598944 [Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma. Amano T, Iijima H, Shinzaki S, Tashiro T, Iwatani S, Tani M, Otake Y, Yoshihara T, Sugimoto A, Egawa S, Yamaguchi S, Kinoshita K, Araki M, Hirao M, Sakakibara Y, Hiyama S, Ogawa H, Nagaike K, Murata J, Komori M, Okuda Y, Kizu T, Tsujii Y, Hayashi Y, Inoue T, Takahashi H, Mizushima T, Morii E, Takehara T. BMC Cancer; 2021 Aug 31; 21(1):978. PubMed ID: 34465291 [Abstract] [Full Text] [Related]